The Biobank of the Institute of Hematology and Blood Transfusion (IHBT) in Prague has achieved accreditation in accordance with the ČSN EN ISO 20378 standard, an internationally recognised standard that ensures the competent, impartial and consistent operation of biobanks.
Accreditation was granted for three types of biological material: plasma, DNA, and viable leukocytes. These samples represent a valuable resource for research into hematological and oncological diseases.
Dr. Adéla Benešová, Deputy Head of the Biobank at the Institute of Hematology and Blood Transfusion (IHBT), explains:
“In June 2026, the Biobank of the Institute of Hematology and Blood Transfusion in Prague successfully achieved accreditation in accordance with ČSN EN ISO 20378. This important milestone demonstrates the Biobank’s commitment to the highest quality standards in the processing and storage of biological samples from patients with hematological malignancies, supporting high-quality research and advances in hematological oncology. So far, two biobanks in the Czech BBMRI.CZ network have been accredited.”
Read more about the accreditation on the BBMRI.cz website.
